Cargando…

Der knochenmarktransplantierte Patient auf der Intensivstation

Allogeneic hematopoetic stem cell transplantation yields improved long-term survival for patients with high-risk malignant and non-malignant hematologic disease. However, it is associated with high morbidity and mortality. A proportion of patients need intensive care due to infectious, immunological...

Descripción completa

Detalles Bibliográficos
Autores principales: Stecher, S.-S., Stemmler, H. J., Tischer, J., von Bergwelt-Baildon, M., Liebregts, T., Fraccaroli, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871956/
https://www.ncbi.nlm.nih.gov/pubmed/33564899
http://dx.doi.org/10.1007/s00063-021-00782-8
Descripción
Sumario:Allogeneic hematopoetic stem cell transplantation yields improved long-term survival for patients with high-risk malignant and non-malignant hematologic disease. However, it is associated with high morbidity and mortality. A proportion of patients need intensive care due to infectious, immunological and/or toxic complications. The utility of intensive care unit (ICU) treatments as mechanical ventilation and renal replacement therapy for these patients is uncertain since mortality is high. We describe the most frequent complications and the treatment options concerning the ICU in recipients of allogeneic hematopoetic stem cells.